<HTML>
<HEAD>
<TITLE>Filed by Bowne Pure Compliance</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">
<DIV style="font-size: 10pt">
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>

<P style="font-size: 14pt" align="center"><B>UNITED STATES<BR>
SECURITIES AND
EXCHANGE COMMISSION<BR>
<FONT style="font-size: 12pt">Washington, D.C. 20549
</FONT></B>

<P style="font-size: 18pt" align="center"><B>FORM 8-K</B>

<P style="font-size: 12pt" align="center"><B>CURRENT REPORT<BR>
Pursuant to
Section 13 or 15(d) of The Securities Exchange Act of 1934</B>

<P style="font-size: 10pt" align="center"><B>Date of Report (Date of earliest
event reported): September 3, 2008</B> <b>(September 2, 2008)</b>

<P style="font-size: 24pt" align="center"><B>BIOGOLD FUELS
CORPORATION<BR>
</B><FONT style="font-size: 10pt">(Exact name of registrant as
specified in its charter) </FONT>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="32%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="33%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="32%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>Nevada</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>333-138869</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>20-5609647</B></TD>
 </TR>
 <TR valign="top">
  <TD>(State or other Jurisdiction of Incorporation)</TD>
  <TD>&nbsp;</TD>
  <TD>(Commission File Number)</TD>
  <TD>&nbsp;</TD>
  <TD>(IRS Employer Identification No.)</TD>
 </TR>

</TABLE>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="100%" border="0">

 <TR>
  <TD width="49%">&nbsp;</TD>
  <TD width="1%">&nbsp;</TD>
  <TD width="49%">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD style="border-bottom: #000000 1px solid"><B>1800 Century Park East, Suite 600<BR>
Los Angeles, CA</B></TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid"><B>90067</B></TD>
 </TR>
 <TR valign="top">
  <TD>(Address of Principal Executive Offices)</TD>
  <TD>&nbsp;</TD>
  <TD>(Zip Code)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="center">Registrant&#8217;s telephone number,
including area code: <B>(310) 556-0025</B>
<TABLE style="font-size: 10pt; text-align: center" cellspacing="0"
cellpadding="0" width="30%" border="0">

 <TR>
  <TD width="100%">&nbsp;</TD>
 </TR>
 <TR>
  <TD style="border-bottom: #000000 1px solid" nowrap><B>&nbsp;</B></TD>
 </TR>
 <TR>
  <TD nowrap>(Former name or former address if changed since last report.)</TD>
 </TR>

</TABLE>


<P style="font-size: 10pt" align="left">Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:

<P style="font-size: 10pt" align="left"><FONT face="Wingdings">o</FONT> Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)<BR>
<BR>
<FONT face="Wingdings">o</FONT> Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))<BR>
<BR>
<FONT
face="Wingdings">o</FONT> Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))<BR>


<DIV
style="margin-top: 10pt; font-size: 1pt; width: 100%; border-bottom: black 1pt solid">&nbsp;</DIV>
<DIV
style="font-size: 1pt; width: 100%; border-bottom: black 2pt solid">&nbsp;</DIV>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">1
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left"><B>SAFE HARBOR STATEMENT UNDER THE
PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995</B>

<P style="font-size: 10pt; text-indent: 4%" align="left">Information included
in this Form 8-K may contain forward-looking statements within the meaning of
Section&nbsp;27A of the Securities Act and Section&nbsp;21E of the Securities
Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). This
information may involve known and unknown risks, uncertainties and other
factors which may cause BioGold Fuels Corp. (&#8220;BioGold&#8221; or the
&#8220;Company&#8221;) actual results, performance or achievements to be
materially different from future results, performance or achievements expressed
or implied by any forward-looking statements. Forward-looking statements, which
involve assumptions and describe BioGold future plans, strategies and
expectations, are generally identifiable by use of the words &#8220;may,&#8221;
&#8220;will,&#8221; &#8220;should,&#8221; &#8220;expect,&#8221;
&#8220;anticipate,&#8221; &#8220;estimate,&#8221; &#8220;believe,&#8221;
&#8220;intend&#8221; or &#8220;project&#8221; or the negative of these words or
other variations on these words or comparable terminology. Forward-looking
statements are based on assumptions that may be incorrect, and there can be no
assurance that any projections or other expectations included in any
forward-looking statements will come to pass. BioGold actual results could
differ materially from those expressed or implied by the forward-looking
statements as a result of various factors. Except as required by applicable
laws, BioGold undertakes no obligation to update publicly any forward-looking
statements for any reason, even if new information becomes available or other
events occur in the future.

<P style="font-size: 10pt" align="left"><B>Section&nbsp;1 &#8212;
Registrant&#8217;s Business and Operations</B>

<P style="font-size: 10pt" align="left"><B>Item&nbsp;1.01 Entry into a Material
Definitive Agreement</B>

<P style="font-size: 10pt" align="left">On September&nbsp;2, 2008, BioGold
Fuels Corporation, a Nevada corporation (&#8220;BioGold&#8221; or the
&#8220;Company&#8221;) entered into a Securities Purchase Agreement with
Heritage Opportunity Fund, LLC, a California limited liability company
(&#8220;Lender&#8221;) pursuant to which BioGold issued to Lender a Senior
Secured Convertible Promissory Note in the principal amount of $287,500 (the
&#8220;Note&#8221;) and a Warrant to purchase 1,437,500 shares of the BioGold
common stock (the &#8220;Warrant&#8221;). The Lender, at its sole option, may
cause the Company to issue a second note and second warrant on terms identical
to the Note and the Warrant on or before October&nbsp;1, 2008 and a third note
and third warrant on terms identical to the Note and the Warrant on or before
November&nbsp;1, 2008 (respectively, the &#8220;Second Note&#8221;, the
&#8220;Second Warrant,&#8221; the &#8220;Third Note,&#8221; and the
&#8220;Third Warrant&#8221;).

<P style="font-size: 10pt" align="left">The Note is due and payable on
August&nbsp;31, 2009.&nbsp;&nbsp;The Note bears interest at the rate of 15% per
annum and the Lender receives a 15% origination fee on the additional proceeds
from the Note, which is deducted from the payment of principal at the time the
funds are disbursed. In conjunction with the issuance of the Note and Warrant,
the due date on the Senior Secured Promissory Note issued to the Lender on
March&nbsp;3, 2008, in the principal amount of $550,000 (the &#8220;$550,000
Note&#8221;) was extended from December&nbsp;31, 2008, to December&nbsp;31,
2009. The Note and the Warrant were issued pursuant to a Securities Purchase
Agreement.

<P style="font-size: 10pt" align="left">To secure the Note, the Lender has been
granted a first priority interest in all of the assets of the Company pursuant
to the terms and conditions of a Security Agreement dated September&nbsp;2,
2008. The Note allows prepayment only upon Lender&#8217;s prior written consent
to remove the security interest.&nbsp;&nbsp;In addition, the Note is
convertible at the Lender&#8217;s discretion into shares of common stock of the
Company at a conversion price equal to the lower of (i) $0.10 per share, or
(ii)&nbsp;the price per share of common stock issued to any investor in the
Company (other than employees, consultants, directors or strategic partners)
subsequent to the date of the First Note.

<P style="font-size: 10pt" align="left">The Warrant is exercisable for five
shares of common stock in the Company for each $1 of principal under the Note.
The exercise price of the Warrant is $0.23 per share which is equal to the
closing price of the Company&#8217;s common stock on the day the Note was
issued. The Warrant has a term of seven years and includes a net issue exercise
provision.

<P style="font-size: 10pt" align="left">The complete terms and conditions of
the foregoing transaction are set forth in the Note, Security Agreement,
Securities Purchase Agreement, and Form of Warrant which are attached hereto as
exhibits and incorporated by reference.


<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">2
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">

<P style="font-size: 10pt" align="left">Under the Securities Purchase
Agreement, the Company is required to file a registration statement with the
Securities and Exchange Commission on or before December&nbsp;31, 2008, to
register under the Securities Act of 1933, as amended, (the &#8220;Securities
Act&#8221;) the shares to be received by the Lender upon conversion of the
Note, the Warrant, the $550,000 Note and, if issued, the Second Note, the
Second Warrant, the Third Note and the Third Warrant

<P style="font-size: 10pt" align="left"><B>Section&nbsp;2 &#8211; Financial
Information</B>

<P style="font-size: 10pt" align="left"><B>Item&nbsp;2. 03</B>&nbsp;<B>Creation
of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant.</B>

<P style="font-size: 10pt" align="left">The information at Item&nbsp;1.01 above
is incorporated herein by reference.

<P style="font-size: 10pt" align="left"><B>Section&nbsp;3 Securities and
Trading Markets</B>

<P style="font-size: 10pt" align="left"><B>Item&nbsp;3.02 Unregistered Sales of
Equity Securities</B>

<P style="font-size: 10pt" align="left">The shares of BioGold common stock
which may be issued upon conversion of the Note, the Warrant, and, if issued,
the Second Note, the Second Warrant, the Third Note and the Third Warrant were
sold to the Lender in a private transaction not involving a public offering.
Based on certain representations and warranties of the Lender in the Securities
Purchase Agreement, BioGold relied on Section&nbsp;4(2) of the Securities Act
for an exemption from the registration requirements of the Securities Act. Such
shares have not been registered under the Securities Act of 1933, as amended,
and may not be sold in the United States absent registration or an applicable
exemption from registration requirements. See Item&nbsp;1.01 above for a
description of the requirement that the Company file a registration statement
to register such shares under the Securities Act.

<P style="font-size: 10pt" align="left"><B>Section&nbsp;5 Corporate Governance
and Management</B>

<P style="font-size: 10pt" align="left"><B>Item&nbsp;5.01 Changes in Control of
Registrant</B>

<P style="font-size: 10pt" align="left">In the event the Lender converts the
entire principal amounts of the Note, the Warrant, the $550,000 Note, and, if
issued, the Second Note, the Second Warrant, the Third Note and the Third
Warrant, the Lender would own a total of 35,688,000 shares or approximately
31.6% of the total number of then outstanding shares making the Lender the
largest shareholder of the Company. As a result, the Lender may be in a
position to exert management control over the Company

<P style="font-size: 10pt" align="left"><B>Section&nbsp;7 Regulation&nbsp;FD</B>

<P style="font-size: 10pt" align="left"><B>Item&nbsp;7.01 Regulation&nbsp;FD
Disclosure</B>

<P style="font-size: 10pt" align="left">On September&nbsp;3, 2008, the Company
issued a press release announcing the entry into the Financing with Heritage as
described in Section&nbsp;1.01 above. A copy of the press release is attached
hereto as Exhibit&nbsp;99.1.







<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">3
</DIV>




<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV
style="margin-left: 0.25in; width: 7.2in; font-family: 'Times New Roman',Times,serif">





<P style="font-size: 10pt" align="left"><B>SECTION 9 &#8211; FINANCIAL
STATEMENTS AND EXHIBITS</B>

<P style="font-size: 10pt" align="left"><B>Item&nbsp;9.01 Exhibits.</B>

<P style="font-size: 10pt; text-indent: 4%"
align="left">(d)&nbsp;<U>Exhibits</U>. The following exhibits are filed
herewith:


<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="8%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="87%">&nbsp;</TD>
 </TR>
 <TR style="font-size: 10pt" valign="bottom">
  <TD nowrap align="left">Exhibit</TD>
  <TD>&nbsp;</TD>
  <TD nowrap align="center">&nbsp;</TD>
 </TR>
 <TR style="font-size: 10pt" valign="bottom">
  <TD style="border-bottom: #000000 1px solid" nowrap align="left">Number</TD>
  <TD>&nbsp;</TD>
  <TD style="border-bottom: #000000 1px solid" nowrap
align="center">Document</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">10.1 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Senior Secured Promissory Note dated
September&nbsp;2, 2008.<br><br></TD>
 </TR>


 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">10.2 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Securities Purchase Agreement dated
September&nbsp;2, 2008.<br><br></TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">10.3 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Security Agreement dated September&nbsp;2,
2008.<br><br></TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">10.4 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Form of Warrant.<br><br></TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">99.1 </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">Press Release dated September&nbsp;3, 2008
regarding entry into Financing with Heritage.</TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center"><B>SIGNATURES</B><BR>
&nbsp;

<P style="font-size: 10pt" align="left">Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized. <BR>
&nbsp;
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" cellpadding="0" width="100%"
border="0">
<!-- Begin Table Head -->

 <TR valign="bottom">
  <TD width="43%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="6%">&nbsp;</TD>
  <TD width="5%">&nbsp;</TD>
  <TD width="41%">&nbsp;</TD>
 </TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp; </TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left" colspan="3"><B>BIOGOLD FUELS
CORPORATION</B></TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px"><BR>
&nbsp; </DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp;<BR>
&nbsp; </TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">&nbsp;<BR>
&nbsp;</TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top">
<DIV style="margin-left: 0px; text-indent: 0px">Date: <B>September&nbsp;3,
2008</B>&nbsp;</DIV>
</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left">By:&nbsp;&nbsp; </TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left" style="border-bottom: 1px solid #000000">/s/ Chris Barsness</TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top" align="left" colspan="3">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left"><B>Chris Barsness</B></TD>
 </TR>
 <TR valign="bottom">
  <TD valign="top" align="left" colspan="3">&nbsp;</TD>
  <TD>&nbsp;</TD>
  <TD valign="top" align="left"><B>Chief Financial Officer</B></TD>
 </TR>
<!-- End Table Body -->

</TABLE>
</DIV>

<P style="font-size: 10pt" align="center">&nbsp;

<P style="display: none; font-size: 10pt" align="center">4
</DIV>
</BODY>
</HTML>
[{"type": "8-K", "sequence": "1", "filename": "c75075e8vk.htm", "description": "8-K", "secsgml_size_bytes": 17491}]
{"company-data": {"conformed-name": "Biogold Fuels CORP", "cik": "0001381192", "assigned-sic": "2860", "irs-number": "205609647", "state-of-incorporation": "NV", "fiscal-year-end": "1231"}, "filing-values": {"form-type": "8-K", "act": "34", "file-number": "333-138869", "film-number": "081055618"}, "business-address": {"street1": "1800 CENTURY PARK E,", "street2": "SUITE 600", "city": "LOS ANGELES", "state": "CA", "zip": "90067", "phone": "(310) 556-0025"}, "mail-address": {"street1": "1800 CENTURY PARK E,", "street2": "SUITE 600", "city": "LOS ANGELES", "state": "CA", "zip": "90067"}, "former-company": {"former-conformed-name": "CAB-TIVE ADVERTISING, INC.", "date-changed": "20061115"}}
Filed by Bowne Pure Compliance
UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of The Securities Exchange Act of 1934
Date of Report (Date of earliest
event reported): September 3, 2008
(September 2, 2008)
BIOGOLD FUELS
CORPORATION
(Exact name of registrant as
specified in its charter)
Nevada
333-138869
20-5609647
(State or other Jurisdiction of Incorporation)
(Commission File Number)
(IRS Employer Identification No.)
1800 Century Park East, Suite 600
Los Angeles, CA
90067
(Address of Principal Executive Offices)
(Zip Code)
Registrant's telephone number,
including area code:
(310) 556-0025
(Former name or former address if changed since last report.)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of
the registrant under any of the following provisions:
o
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o
Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
SAFE HARBOR STATEMENT UNDER THE
PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995
Information included
in this Form 8-K may contain forward-looking statements within the meaning of
Section 27A of the Securities Act and Section 21E of the Securities
Exchange Act of 1934, as amended (the "Exchange Act"). This
information may involve known and unknown risks, uncertainties and other
factors which may cause BioGold Fuels Corp. ("BioGold" or the
"Company") actual results, performance or achievements to be
materially different from future results, performance or achievements expressed
or implied by any forward-looking statements. Forward-looking statements, which
involve assumptions and describe BioGold future plans, strategies and
expectations, are generally identifiable by use of the words "may,"
"will," "should," "expect,"
"anticipate," "estimate," "believe,"
"intend" or "project" or the negative of these words or
other variations on these words or comparable terminology. Forward-looking
statements are based on assumptions that may be incorrect, and there can be no
assurance that any projections or other expectations included in any
forward-looking statements will come to pass. BioGold actual results could
differ materially from those expressed or implied by the forward-looking
statements as a result of various factors. Except as required by applicable
laws, BioGold undertakes no obligation to update publicly any forward-looking
statements for any reason, even if new information becomes available or other
events occur in the future.
Section 1 —
Registrant's Business and Operations
Item 1.01 Entry into a Material
Definitive Agreement
On September 2, 2008, BioGold
Fuels Corporation, a Nevada corporation ("BioGold" or the
"Company") entered into a Securities Purchase Agreement with
Heritage Opportunity Fund, LLC, a California limited liability company
("Lender") pursuant to which BioGold issued to Lender a Senior
Secured Convertible Promissory Note in the principal amount of $287,500 (the
"Note") and a Warrant to purchase 1,437,500 shares of the BioGold
common stock (the "Warrant"). The Lender, at its sole option, may
cause the Company to issue a second note and second warrant on terms identical
to the Note and the Warrant on or before October 1, 2008 and a third note
and third warrant on terms identical to the Note and the Warrant on or before
November 1, 2008 (respectively, the "Second Note", the
"Second Warrant," the "Third Note," and the
"Third Warrant").
The Note is due and payable on
August 31, 2009.  The Note bears interest at the rate of 15% per
annum and the Lender receives a 15% origination fee on the additional proceeds
from the Note, which is deducted from the payment of principal at the time the
funds are disbursed. In conjunction with the issuance of the Note and Warrant,
the due date on the Senior Secured Promissory Note issued to the Lender on
March 3, 2008, in the principal amount of $550,000 (the "$550,000
Note") was extended from December 31, 2008, to December 31,
2009. The Note and the Warrant were issued pursuant to a Securities Purchase
Agreement.
To secure the Note, the Lender has been
granted a first priority interest in all of the assets of the Company pursuant
to the terms and conditions of a Security Agreement dated September 2,
2008. The Note allows prepayment only upon Lender's prior written consent
to remove the security interest.  In addition, the Note is
convertible at the Lender's discretion into shares of common stock of the
Company at a conversion price equal to the lower of (i) $0.10 per share, or
(ii) the price per share of common stock issued to any investor in the
Company (other than employees, consultants, directors or strategic partners)
subsequent to the date of the First Note.
The Warrant is exercisable for five
shares of common stock in the Company for each $1 of principal under the Note.
The exercise price of the Warrant is $0.23 per share which is equal to the
closing price of the Company's common stock on the day the Note was
issued. The Warrant has a term of seven years and includes a net issue exercise
provision.
The complete terms and conditions of
the foregoing transaction are set forth in the Note, Security Agreement,
Securities Purchase Agreement, and Form of Warrant which are attached hereto as
exhibits and incorporated by reference.
Under the Securities Purchase
Agreement, the Company is required to file a registration statement with the
Securities and Exchange Commission on or before December 31, 2008, to
register under the Securities Act of 1933, as amended, (the "Securities
Act") the shares to be received by the Lender upon conversion of the
Note, the Warrant, the $550,000 Note and, if issued, the Second Note, the
Second Warrant, the Third Note and the Third Warrant
Section 2 – Financial
Information
Item 2. 03
Creation
of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet
Arrangement of a Registrant.
The information at Item 1.01 above
is incorporated herein by reference.
Section 3 Securities and
Trading Markets
Item 3.02 Unregistered Sales of
Equity Securities
The shares of BioGold common stock
which may be issued upon conversion of the Note, the Warrant, and, if issued,
the Second Note, the Second Warrant, the Third Note and the Third Warrant were
sold to the Lender in a private transaction not involving a public offering.
Based on certain representations and warranties of the Lender in the Securities
Purchase Agreement, BioGold relied on Section 4(2) of the Securities Act
for an exemption from the registration requirements of the Securities Act. Such
shares have not been registered under the Securities Act of 1933, as amended,
and may not be sold in the United States absent registration or an applicable
exemption from registration requirements. See Item 1.01 above for a
description of the requirement that the Company file a registration statement
to register such shares under the Securities Act.
Section 5 Corporate Governance
and Management
Item 5.01 Changes in Control of
Registrant
In the event the Lender converts the
entire principal amounts of the Note, the Warrant, the $550,000 Note, and, if
issued, the Second Note, the Second Warrant, the Third Note and the Third
Warrant, the Lender would own a total of 35,688,000 shares or approximately
31.6% of the total number of then outstanding shares making the Lender the
largest shareholder of the Company. As a result, the Lender may be in a
position to exert management control over the Company
Section 7 Regulation FD
Item 7.01 Regulation FD
Disclosure
On September 3, 2008, the Company
issued a press release announcing the entry into the Financing with Heritage as
described in Section 1.01 above. A copy of the press release is attached
hereto as Exhibit 99.1.
SECTION 9 – FINANCIAL
STATEMENTS AND EXHIBITS
Item 9.01 Exhibits.
(d)
Exhibits
. The following exhibits are filed
herewith:
Exhibit
Number
Document
10.1
Senior Secured Promissory Note dated
September 2, 2008.
10.2
Securities Purchase Agreement dated
September 2, 2008.
10.3
Security Agreement dated September 2,
2008.
10.4
Form of Warrant.
99.1
Press Release dated September 3, 2008
regarding entry into Financing with Heritage.
SIGNATURES
Pursuant to the requirements of the
Securities Exchange Act of 1934, the registrant has duly caused this report to
be signed on its behalf by the undersigned hereunto duly authorized.
BIOGOLD FUELS
CORPORATION
Date:
September 3,
2008
By:
/s/ Chris Barsness
Chris Barsness
Chief Financial Officer